BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9584218)

  • 1. A comparison of thermodynamic parameters for vinorelbine- and vinflunine-induced tubulin self-association by sedimentation velocity.
    Lobert S; Ingram JW; Hill BT; Correia JJ
    Mol Pharmacol; 1998 May; 53(5):908-15. PubMed ID: 9584218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of vinca alkaloids with tubulin: a comparison of vinblastine, vincristine, and vinorelbine.
    Lobert S; Vulevic B; Correia JJ
    Biochemistry; 1996 May; 35(21):6806-14. PubMed ID: 8639632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Energetics of vinca alkaloid interactions with tubulin isotypes: implications for drug efficacy and toxicity.
    Lobert S; Frankfurter A; Correia JJ
    Cell Motil Cytoskeleton; 1998; 39(2):107-21. PubMed ID: 9484953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloid.
    Kruczynski A; Barret JM; Etiévant C; Colpaert F; Fahy J; Hill BT
    Biochem Pharmacol; 1998 Mar; 55(5):635-48. PubMed ID: 9515574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divalent cation and ionic strength effects on Vinca alkaloid-induced tubulin self-association.
    Lobert S; Boyd CA; Correia JJ
    Biophys J; 1997 Jan; 72(1):416-27. PubMed ID: 8994628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel actions of the antitumor drugs vinflunine and vinorelbine on microtubules.
    Ngan VK; Bellman K; Panda D; Hill BT; Jordan MA; Wilson L
    Cancer Res; 2000 Sep; 60(18):5045-51. PubMed ID: 11016627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vinflunine, a novel microtubule inhibitor, suppresses calmodulin interaction with the microtubule-associated protein STOP.
    Makarov AA; Tsvetkov PO; Villard C; Esquieu D; Pourroy B; Fahy J; Braguer D; Peyrot V; Lafitte D
    Biochemistry; 2007 Dec; 46(51):14899-906. PubMed ID: 18052208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The thermodynamics of vinca alkaloid-induced tubulin spirals formation.
    Lobert S; Ingram JW; Correia JJ
    Biophys Chem; 2007 Mar; 126(1-3):50-8. PubMed ID: 16757093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vinflunine, a new vinca alkaloid: cytotoxicity, cellular accumulation and action on the interphasic and mitotic microtubule cytoskeleton of PtK2 cells.
    Jean-Decoster C; Brichese L; Barret JM; Tollon Y; Kruczynski A; Hill BT; Wright M
    Anticancer Drugs; 1999 Jul; 10(6):537-43. PubMed ID: 10885901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of guanine nucleotides in the vinblastine-induced self-association of tubulin: effects of guanosine alpha,beta-methylenetriphosphate and guanosine alpha,beta-methylenediphosphate.
    Vulevic B; Lobert S; Correia JJ
    Biochemistry; 1997 Oct; 36(42):12828-35. PubMed ID: 9335540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of mitotic block and inhibition of cell proliferation by the semisynthetic Vinca alkaloids vinorelbine and its newer derivative vinflunine.
    Ngan VK; Bellman K; Hill BT; Wilson L; Jordan MA
    Mol Pharmacol; 2001 Jul; 60(1):225-32. PubMed ID: 11408618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additivity of dilantin and vinblastine inhibitory effects on microtubule assembly.
    Lobert S; Ingram JW; Correia JJ
    Cancer Res; 1999 Oct; 59(19):4816-22. PubMed ID: 10519390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential binding to the alpha/beta-tubulin dimer of vinorelbine and vinflunine revealed by nuclear magnetic resonance analyses.
    Fabre C; Czaplicki J; Wright M; Hill B; Barret JM; Fahy J; Milon A
    Biochem Pharmacol; 2002 Aug; 64(4):733-40. PubMed ID: 12167492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical in vivo antitumor activity of vinflunine, a novel fluorinated Vinca alkaloid.
    Kruczynski A; Colpaert F; Tarayre JP; Mouillard P; Fahy J; Hill BT
    Cancer Chemother Pharmacol; 1998; 41(6):437-47. PubMed ID: 9554586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vinflunine, the latest Vinca alkaloid in clinical development. A review of its preclinical anticancer properties.
    Kruczynski A; Hill BT
    Crit Rev Oncol Hematol; 2001 Nov; 40(2):159-73. PubMed ID: 11682323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of vinblastine to phosphocellulose-purified and alpha beta-class III tubulin: the role of nucleotides and beta-tubulin isotypes.
    Lobert S; Frankfurter A; Correia JJ
    Biochemistry; 1995 Jun; 34(25):8050-60. PubMed ID: 7794918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the mechanisms of action of the novel microtubule inhibitor vinflunine.
    Jordan MA; Horwitz SB; Lobert S; Correia JJ
    Semin Oncol; 2008 Jun; 35(3 Suppl 3):S6-S12. PubMed ID: 18538179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics, metabolites, and preclinical safety of vinflunine.
    Lobert S; Puozzo C
    Semin Oncol; 2008 Jun; 35(3 Suppl 3):S28-33. PubMed ID: 18538176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine leukemia P388 vinorelbine-resistant cell lines are sensitive to vinflunine.
    Aggarwal A; Kruczynski A; Frankfurter A; Correia JJ; Lobert S
    Invest New Drugs; 2008 Aug; 26(4):319-30. PubMed ID: 18071633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential in vitro association of vinca alkaloid-induced tubulin spiral filaments into aggregated spirals.
    Verdier-Pinard P; Garès M; Wright M
    Biochem Pharmacol; 1999 Sep; 58(6):959-71. PubMed ID: 10509748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.